Purdue Pharma’s Sackler family owners have struck a new agreement to settle mass opioid litigation against them for a total of $6.5 billion, New York Attorney General Letitia James said Thursday.

Purdue Pharma and Owners to Pay $7.4 Billion in Settlement ... They’ve continued to deny claims of any wrongdoing. Collectively, family members have been estimated to be worth billions more ...

Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.

Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 ... They’ve continued to deny claims of any wrongdoing.Collectively, family members have been estimated ...

Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.

Purdue Pharma’s Sackler ... receive most of the settlement proceeds for opioid treatment and mitigation programs, while some of the money will go toward individuals who claim that they or ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... They’ve continued to deny claims of any wrongdoing. Collectively, family members have been estimated ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... They’ve continued to deny claims of any wrongdoing. Collectively, family members have been estimated ...